TABLE 2.
Per-Patient Analysis of CMA over 12 Months
| 3 mo | 6 mo | 12 mo | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Parameter | Total | No activity | Low activity | High activity | No activity | Low activity | High activity | No activity | Low activity | High activity |
| All participants | 111 | |||||||||
| Baseline CMA | ||||||||||
| No activity (CMA = 0) | 31/111 (28%) | 5/32 (16%) | 0/32 (0%) | 2/32 (6%) | 8/40 (20%) | 2/40 (5%) | 2/40 (5%) | 11/39 (28%) | 1/39 (3%) | 0/39 (0%) |
| Low activity (CMA > 0 and ≤ 1.56) | 38/111 (34%) | 6/32 (19%) | 5/32 (16%) | 1/32 (3%) | 5/40 (13%) | 2/40 (5%) | 3/40 (8%) | 3/39 (8%) | 8/39 (21%) | 5/39 (13%) |
| High activity (CMA > 1.56) | 42/111 (38%) | 0/32 (0%) | 4/32 (13%) | 9/32 (28%) | 1/40 (3%) | 2/40 (5%) | 15/40 (38%) | 3/39 (8%) | 3/39 (8%) | 5/39 (13%) |
| Recent acute myocardial infarction | 52 | |||||||||
| No activity (CMA = 0) | 23/52 (44%) | 3/12 (25%) | 0/12 (0%) | 1/12 (8%) | 5/20 (25%) | 2/20 (10%) | 1/20 (5%) | 10/20 (50%) | 1/20 (10%) | 0/20 (0%) |
| Low activity (CMA > 0 and ≤ 1.56) | 13/52 (25%) | 2/12 (17%) | 3/12 (25%) | 0/12 (0%) | 1/20 (5%) | 1/20 (5%) | 2/20 (10%) | 1/20 (5%) | 0/20 (0%) | 3/20 (15%) |
| High activity (CMA > 1.56) | 16/52 (31%) | 0/12 (0%) | 0/12 (0)% | 3/12 (25%) | 1/20 (5%) | 2/20 (10%) | 5/20 (25%) | 1/20 (5%) | 2/20 (10%) | 2/20 (10%) |
| Advanced chronic coronary artery disease | 59 | |||||||||
| No activity (CMA = 0) | 8/59 (14%) | 2/20 (10%) | 0/20 (0%) | 1/20 (5%) | 3/20 (15%) | 0/20 (0%) | 1/20 (5%) | 1/19 (5%) | 0/19 (0%) | 0/19 (0%) |
| Low activity (CMA > 0 and ≤ 1.56) | 25/59 (42%) | 4/20 (20%) | 2/20 (10%) | 1/20 (5%) | 4/20 (20%) | 1/20 (5%) | 1/20 (5%) | 2/19 (11%) | 8/19 (42%) | 2/19 (10.5%) |
| High activity (CMA > 1.56) | 26/59 (44%) | 0/20 (0%) | 4/20 (20%) | 6/20 (30%) | 0/20 (0%) | 0/20 (0%) | 10/20 (50%) | 2/19 (11%) | 1/19 (5%) | 3/19 (16%) |